Dr Robert A Caserta, MD | |
2979 Main St, Bridgeport, CT 06606-4252 | |
(203) 333-8800 | |
(203) 384-5157 |
Full Name | Dr Robert A Caserta |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 2979 Main St, Bridgeport, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265438279 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 018304 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert A Caserta, MD 2979 Main St, Bridgeport, CT 06606-4252 Ph: (203) 333-8800 | Dr Robert A Caserta, MD 2979 Main St, Bridgeport, CT 06606-4252 Ph: (203) 333-8800 |
News Archive
At the 19th Annual Conference of the American Society of Neural Therapy and Repair (ASNTR), held April 26 - 28 in Clearwater Beach, Florida, the ASNTR awarded The 2012 Bernard Sanberg Memorial Award for Brain Repair to Timothy J. Collier, PhD, professor of translational science and molecular medicine at Michigan State University and director of the Udall Center of Excellence in Parkinson's Disease Research at Michigan State University and the University of Cincinnati. ASNTR also presented The Molly and Bernard Sanberg Memorial Award to Sean I. Savitz, MD, associat
The Side-Out Foundation and its Dig Pink- Volleyball Breast Cancer Awareness campaign will launch a first of its kind clinical trial this month to examine the effects of individualized treatment on patients with metastatic breast cancer.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are proud to announce the collaborative development of practice and training guidelines in the practice of urologic ultrasound which has led to the availability of practice accreditation through the AIUM.
Scientists at the Buck Institute for Age Research have discovered that a particular family of enzymes are involved in the breakdown of proteins that modify the production of toxic fragments that lead to the pathology of Huntington's disease. These enzymes, matrix metalloproteinases, provide new targets for drug therapies for the disease - targets that have already been shown to respond to cancer drugs currently in clinical development.
› Verified 6 days ago
Mitchell Andrew Fogel, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 900 Madison Ave, Suite 209, Bridgeport, CT 06606 Phone: 203-335-0195 Fax: 203-335-7293 | |
Christian Heineken, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3180 Main St, Suite 301, Bridgeport, CT 06606 Phone: 203-373-9100 Fax: 203-365-8492 | |
Pasquale Masone, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3180 Main St, Suite 301, Bridgeport, CT 06606 Phone: 203-373-9100 Fax: 203-365-8492 | |
Kevin B Panzer, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1381 Reservoir Ave., Bridgeport, CT 06606 Phone: 203-371-5197 | |
Ms. Lucia Plichtova, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 267 Grant Street, Bridgeport, CT 06610 Phone: 203-384-3792 | |
Hilda Daureen Kyotakoze, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4920 Main St Fl 2, Bridgeport, CT 06606 Phone: 203-371-2986 | |
Karen A Hutchinson, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 226 Mill Hill Ave, 3rd Floor, Bridgeport, CT 06610 Phone: 203-384-3873 Fax: 203-384-3829 |